Clinical trial
Analysis of a Biomarker Signature, Consisting of Toll-like Receptor 2 (TLR2), TLR4 and CCR1, by Flow Cytometry in Patients With MS Treated With Gilenya (FTY720)
NCT02408380 is registered in ClinicalTrials.gov with McGill University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of a Biomarker Signature, Consisting of Toll-like Receptor 2 (TLR2), TLR4 and CCR1, by Flow Cytometry in Patients With MS Treated With Gilenya (FTY720)
- Lead sponsor
- McGill University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- December 31, 2015
- Enrollment
- 216 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.